Literature DB >> 10766869

Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor.

G Verrijdt1, E Schoenmakers, A Haelens, B Peeters, G Verhoeven, W Rombauts, F Claessens.   

Abstract

The androgen and glucocorticoid receptors recognize identical DNA motifs, leaving unanswered the question of how steroid specificity of transcriptional regulation is established in cells containing both receptors. Here, we provide evidence that subtle differences in low affinity DNA recognition might be a crucial element in the generation of steroid-specific responses. Here we identify simple hormone response elements in the mouse sex-limited protein enhancer and the human secretory component androgen response unit to be essential for the androgen specificity of both enhancers. We describe specific in vitro binding to these motifs by the DNA-binding domain of the androgen but not the glucocorticoid receptor. Both elements can be considered partial direct repeats of the 5'-TGTTCT-3' core binding motif. In addition, we show that specific point mutations in their left half-sites, essentially changing the nature of the repeats, strongly enhance the glucocorticoid sensitivity of the respective enhancers, whereas they have no effect on their androgen responsiveness. Accordingly, these mutations allow specific binding of the glucocorticoid receptor DNA-binding domain to both elements in vitro. With these experiments, we demonstrate that differential recognition by the androgen receptor of nonconventional steroid response elements is, at least in some cases, an important mechanism in androgen-specific transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766869     DOI: 10.1074/jbc.275.16.12298

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.

Authors:  Guy Verrijdt; Annemie Haelens; Erik Schoenmakers; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

2.  DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.

Authors:  Annemie Haelens; Guy Verrijdt; Leen Callewaert; Valerie Christiaens; Kris Schauwaers; Ben Peeters; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

Review 3.  Androgen receptor and miR-206 regulation in prostate cancer.

Authors:  Fu Y Chua; Brian D Adams
Journal:  Transcription       Date:  2017-06-09

Review 4.  The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.

Authors:  Amy B Cadwallader; Carol S Lim; Douglas E Rollins; Francesco Botrè
Journal:  J Anal Toxicol       Date:  2011-11       Impact factor: 3.367

5.  Hey1, a mediator of notch signaling, is an androgen receptor corepressor.

Authors:  Borja Belandia; Sue M Powell; Juana M García-Pedrero; Marjorie M Walker; Charlotte L Bevan; Malcolm G Parker
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  The rules of DNA recognition by the androgen receptor.

Authors:  Sarah Denayer; Christine Helsen; Lieven Thorrez; Annemie Haelens; Frank Claessens
Journal:  Mol Endocrinol       Date:  2010-03-19

7.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

8.  Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.

Authors:  W Zhai; Y Sun; M Jiang; M Wang; T A Gasiewicz; J Zheng; C Chang
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

9.  The Role of Androgen Receptor in Breast Cancer.

Authors:  Domenico Iacopetta; Yassine Rechoum; Suzanne Aw Fuqua
Journal:  Drug Discov Today Dis Mech       Date:  2012

10.  The transcription intermediary factor 1β coactivates the androgen receptor.

Authors:  N Van Tilborgh; L Spans; C Helsen; L Clinckemalie; V Dubois; E Lerut; S Boonen; D Vanderschueren; F Claessens
Journal:  J Endocrinol Invest       Date:  2013-04-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.